BVS857

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for BVS857, covering 2015-04-24 to 2017-08-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy [Phase 2]